Speculating in Takeover Targets Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Speculating in Takeover Targets

ULBI 5.660

+2.4%

Dec 3 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: richardred	11/20/2006 10:16:29 AM
	Read Replies (1) of 7252

Movers today. AGN, MTR, but not forgotten. >Last month, Botox maker Allergan Inc. (NYSE:AGN - News) offered $3.2 billion for Inamed Corp. (NasdaqNM:IMDC - News). This prompted statements from Inamed shareholder S.A.C. Capital Advisors and eventually forced Medicis Pharmaceutical Corp. (NYSE:MRX - News) to scrap its planned $2.5 billion deal to buy the company. Medicis itself is the target of an unsolicited bid from breast implant maker Mentor Corp. (NYSE:MNT - News). Message 22110832 Message 22149377 Message 22108537

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next